Skip to main content

Year: 2025

Rio2 Announces Filing of Prospectus Supplement in Connection with Previously Announced “Bought Deal” Equity Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 11, 2025 (GLOBE NEWSWIRE) — Rio2 Limited (“Rio2” or the “Company”) (TSX: RIO; OTCQX: RIOFF; BVL: RIO) today announced that it has filed a prospectus supplement dated December 10, 2025 (the “Prospectus Supplement”), to its short form base shelf prospectus dated October 16, 2024, as amended pursuant to amendment no. 1 to such short form base shelf prospectus dated December 3, 2025 (the “Base Shelf Prospectus”). The Prospectus Supplement was filed with the securities regulatory authorities in each of the provinces and territories of Canada, except Quebec, to qualify the public distribution of 74,865,000 subscription receipts (the “Subscription Receipts”) at a price of $2.22 per Subscription Receipt in...

Continue reading

Willis Lease Finance Corporation Announces Pricing of $392.9 Million in Fixed Rate Notes

COCONUT CREEK, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and global provider of aviation services, announced today that its wholly-owned subsidiary, Willis Engine Structured Trust IX (“WEST”), has priced $337,400,000 in aggregate principal amount of Series A Fixed Rate Notes (the “Series A Notes”) and $55,500,000 in aggregate principal amount of Series B Fixed Rate Notes (the “Series B Notes” and, together with the Series A Notes, the “Notes”). The Notes will be secured by, among other things, WEST’s direct and indirect interests in a portfolio of 47 aircraft engines and two airframes, which WEST will acquire from WLFC or its other subsidiaries pursuant to an asset purchase agreement. The planned closing date...

Continue reading

Cycle Pharmaceuticals to Acquire Applied Therapeutics

Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT; “Applied”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced a definitive agreement for Cycle Group Holdings Limited (“Cycle”) to acquire Applied Therapeutics. Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases. Applied’s lead drug candidate, govorestat, is a novel central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic...

Continue reading

Microbix Schedules Release of Results for Q4 Fiscal 2025

Results Release and Webinar Discussion on Morning of December 18, 2025 MISSISSAUGA, Ontario, Dec. 11, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its fourth quarter of fiscal 2025 ended September 30, 2025 (“Q4 2025”) prior to the start of trading on December 18, 2025. At 10:00 AM ET that day, Microbix intends to hold a webinar discussion of Q4 2025 results with its CEO, CFO, and COO. Investor and shareholders can participate in the webinar, hosted by Adelaide Capital, by registering at: https://us02web.zoom.us/webinar/register/WN_uKFYZc_DTZinjJoUP46rcA. It will also be live-streamed to YouTube at: https://www.youtube.com/channel/UC7Jpt_DWjF1qSCzfKlpLMWw. Or...

Continue reading

Meshflow Acquisition Corp. Announces Closing of $345 Million Initial Public Offering Including Exercise of Underwriters’ Over-Allotment Option in Full

CHICAGO, IL, Dec. 11, 2025 (GLOBE NEWSWIRE) — Meshflow Acquisition Corp. (Nasdaq: MESHU) (the “Company”) today announced the closing of its initial public offering of 34,500,000 units, which includes 4,500,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full, at a public offering price of $10.00 per unit. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. The units are listed on The Nasdaq Global Market (“Nasdaq”) and commenced trading under the ticker symbol “MESHU” on December 10, 2025. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the...

Continue reading

TTEC Recognized as a Major Contender in Everest Group’s 2025 Sales Services PEAK Matrix® Assessment

AUSTIN, Texas, Dec. 11, 2025 (GLOBE NEWSWIRE) — TTEC Holdings, Inc. (NASDAQ: TTEC), a leading global CX (customer experience) technology and services innovator for AI-enhanced CX, today announced that it has been recognized as a Major Contender in the Everest Group Sales Services (B2B & B2C) PEAK Matrix® Assessment 2025. This marks an important milestone for TTEC, representing the first time the company’s end-to-end RevGen capabilities have been evaluated and acknowledged in the Everest Group Sales Services report. In the PEAK Matrix®, providers are categorized as Leaders, Major Contenders, or Aspirants. Major Contenders demonstrate strong capabilities across B2B and B2C sales, delivering scalable engagement models, growing global presence, competitive innovation, and measurable client value. “TTEC has been recognized as a...

Continue reading

DIRTT Announces Financing from BDC and Refinancing of Debentures

CALGARY, Alberta, Dec. 11, 2025 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company“) (TSX: DRT; OTCQX: DRTTF), a leader in industrialized construction, today announced it has entered into a letter agreement (the “Letter“) with the Business Development Bank of Canada (“BDC“), pursuant to which BDC committed to lending the Company up to C$15.0 million (the “Loan“) subject to the satisfaction of certain conditions. “This financing represents another important step in optimizing our capital structure and strategically positions us to continue executing on our transformative growth plan,” said Benjamin Urban, CEO of DIRTT. Following the satisfaction of the conditions precedent set forth in the Letter, BDC will make an initial disbursement to the...

Continue reading

Alpine Banks of Colorado announces stock repurchase program

GLENWOOD SPRINGS, Colo., Dec. 11, 2025 (GLOBE NEWSWIRE) — Alpine Banks of Colorado (OTCQX: ALPIB) (“Alpine” or the “Company”), the holding company for Alpine Bank, announced today that its board of directors has approved a stock repurchase program under which Alpine may purchase up to $5 million of its issued and outstanding Class B voting common stock. The repurchase program is expected to begin on or about February 5, 2026, following the conclusion of Alpine’s exchange offer of Class B voting common stock for Class A voting common stock, previously announced on December 2, 2025. “The stock repurchase program reflects the confidence we have in our future. We believe that it’s a smart way for us to create more value for our shareholders while also giving holders of Class B voting common stock more flexibility and liquidity,” said...

Continue reading

INNEOVA HOLDINGS LIMITED ANNOUNCES RECEIPT OF NASDAQ NOTIFICATION LETTER REGARDING MINIMUM PRICE DEFICIENCY

SINGAPORE, Dec. 11, 2025 (GLOBE NEWSWIRE) — INNEOVA Holdings Limited (“INNEOVA” or the “Company”) (Nasdaq: INEO), a leading Singapore-based provider of high-quality Original Equipment Manufacturer, third-party branded and in-house branded replacement parts for motor vehicles and non-vehicle combustion engines and system lifecycle analysis and engineering services for infrastructure and mobility platforms, today announced that it received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) dated December 8, 2025, notifying the Company that based on the closing bid price of the Company for the period from October 24, 2025 to December 5, 2025, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share. Pursuant to Nasdaq...

Continue reading

Twelve Seas Investment Company III Announces Pricing of $150,000,000 Initial Public Offering

Los Angeles, California, Dec. 11, 2025 (GLOBE NEWSWIRE) — Twelve Seas Investment Company III (NASDAQ: TWLVU) (the “Company”) today announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The Company’s units will be listed on the Nasdaq Global Market under the symbol “TWLVU” and will begin trading on December 12, 2025. Each unit issued in the offering consists of one Class A ordinary share of the Company and one right to receive one tenth (1/10) of a Class A ordinary share upon the consummation of the Company’s initial business combination. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on NASDAQ under the symbols “TWLV” and “TWLVR,” respectively. The closing of the offering is anticipated to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.